UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000003130
Receipt No. R000003793
Scientific Title Randomized Phase III Trail of Liposomal Doxorubicin(PLD)50mg/m2 versus Liposomal Doxorubicin(PLD)40mg/m2 in Patients with Platinum-Refractory and -Resistant Mullerian Carcinoma (Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma).
Date of disclosure of the study information 2010/02/02
Last modified on 2018/08/16 12:00:50

No. Disposal Last modified on Item of update
1 Insert 2010/02/02 15:53:30
2 Update 2010/04/20 11:42:57 Email
Institutions
3 Update 2010/04/20 12:00:17 Key inclusion criteria
Key exclusion criteria
Key exclusion criteria
4 Update 2010/06/14 16:11:14 Name of person sending information
Name of person sending information
Organization
Organization
Division name
Institutions
5 Update 2010/07/09 14:00:05 Institutions
6 Update 2010/08/02 10:28:24 Institutions
7 Update 2011/02/02 11:53:24 Institutions
8 Update 2011/07/28 17:09:43 Post marketing survey by drug manufacture etc., specified by Japanese law.
9 Update 2011/07/28 17:10:09 Recruitment status
10 Update 2011/08/02 10:01:22 Institutions
11 Update 2012/02/02 13:13:52 Institutions
12 Update 2012/09/03 11:31:31 Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
13 Update 2013/01/15 10:41:16 Recruitment status
14 Update 2013/02/04 10:35:29 Institutions
15 Update 2013/08/02 10:22:45 Division name
Division name
Organization
16 Update 2014/02/03 10:05:25 Email
17 Update 2014/08/04 11:44:59 Institutions
18 Update 2014/09/26 17:17:30 Target sample size
19 Update 2014/09/26 17:23:09 Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
20 Update 2014/09/26 17:24:54 Institute
21 Update 2015/02/02 11:15:46 Institutions
22 Update 2015/08/04 12:20:05 Name of person sending information
Name of person sending information
Institutions
23 Update 2016/08/08 17:03:40 Randomization unit
24 Update 2016/08/08 17:10:13 Name of person sending information
Name of person sending information
Name of primary sponsor
Organization
Institutions
25 Update 2017/01/24 18:11:25 Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
26 Update 2017/08/08 10:56:01 Institutions
27 Update 2017/08/08 10:57:37 Recruitment status
28 Update 2018/08/16 12:00:50 Results


Contact us.